Literature DB >> 23406868

Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

F R Mooi1, N A T Van Der Maas2, H E De Melker2.   

Abstract

Pertussis or whooping cough has persisted and resurged in the face of vaccination and has become one of the most prevalent vaccine-preventable diseases in Western countries. The high circulation rate of Bordetella pertussis poses a threat to infants that have not been (completely) vaccinated and for whom pertussis is a severe, life-threatening, disease. The increase in pertussis is mainly found in age groups in which immunity has waned and this has resulted in the perception that waning immunity is the main or exclusive cause for the resurgence of pertussis. However, significant changes in B. pertussis populations have been observed after the introduction of vaccinations, suggesting a role for pathogen adaptation in the persistence and resurgence of pertussis. These changes include antigenic divergence with vaccine strains and increased production of pertussis toxin. Antigenic divergence will affect both memory recall and the efficacy of antibodies, while higher levels of pertussis toxin may increase suppression of the innate and acquired immune system. We propose these adaptations of B. pertussis have decreased the period in which pertussis vaccines are effective and thus enhanced the waning of immunity. We plead for a more integrated approach to the pertussis problem which includes the characteristics of the vaccines, the B. pertussis populations and the interaction between the two.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406868      PMCID: PMC9151166          DOI: 10.1017/S0950268813000071

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  62 in total

1.  Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.

Authors:  Anders Hviid; Michael Stellfeld; Peter Henrik Andersen; Jan Wohlfahrt; Mads Melbye
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

Review 2.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 3.  Factors contributing to pertussis resurgence.

Authors:  Qiushui He; Jussi Mertsola
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

4.  Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.

Authors:  Maxwell A Witt; Paul H Katz; David J Witt
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

5.  Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.

Authors:  Sabine C de Greeff; Hester E de Melker; Anneke Westerhof; Joop F P Schellekens; Frits R Mooi; Michiel van Boven
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

6.  Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

Authors:  Lennart Gustafsson; Luc Hessel; Jann Storsaeter; Patrick Olin
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

7.  Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

Authors:  Sabine C de Greeff; Hester E de Melker; Pieter G M van Gageldonk; Joop F P Schellekens; Fiona R M van der Klis; Liesbeth Mollema; Frits R Mooi; Guy A M Berbers
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

8.  SNP-based typing: a useful tool to study Bordetella pertussis populations.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Teemu Kallonen; Qiushui He; Jussi Mertsola; Abdolreza Advani; Hans O Hallander; Koen Janssens; Peter W Hermans; Frits R Mooi
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

9.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

10.  Population diversity among Bordetella pertussis isolates, United States, 1935-2009.

Authors:  Amber J Schmidtke; Kathryn O Boney; Stacey W Martin; Tami H Skoff; M Lucia Tondella; Kathleen M Tatti
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

View more
  116 in total

Review 1.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

Review 2.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

3.  The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.

Authors:  Andrew Preston
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

4.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 5.  Bordetella pertussis: new concepts in pathogenesis and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

6.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

7.  Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors:  Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

8.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

9.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

10.  Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Authors:  Claudia Guevara; Chengxian Zhang; Jennifer A Gaddy; Junaid Iqbal; Julio Guerra; David P Greenberg; Michael D Decker; Nicholas Carbonetti; Timothy D Starner; Paul B McCray; Frits R Mooi; Oscar G Gómez-Duarte
Journal:  Infect Dis (Lond)       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.